Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Two groups of scientists have independently identified a genetic variant that significantly raises the risk of heart disease.
A microfluidic chip rapidly identifies pathogens by scanning their genomes.
After outflanking and outlasting competitors, it is on top of the genome-sequencing business—just as that market is about to soar in importance.
A new venture lets patients choose how their data is used for medical research and offers sophisticated privacy settings.
A company has developed a simple blood test to identify most cases of autism—but determining if it really works is not so simple.
A microfluidic chip could measure effectiveness of patient treatments in resource-poor countries.
Researchers are able to predict individuals’ ages from DNA modifications in their saliva.
Rising levels of donor DNA in recipients’ blood could mean the organ is in danger.
A startup is developing sequencing-based tests that could detect infections within 24 hours.